Zinc and copper complexes of prodigiosin: Implications for copper-mediated double-strand DNA cleavage

Organic Letters

Volumn 5, Issue 2, 2003, Pages 113-116

  Park, Gyungse ^a   Tomlinson, John T ^a   Melvin, Matt S ^a   Wright, Marcus W ^a   Day, Cynthia S ^a   Manderville, Richard A ^a  

^a WAKE FOREST UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER COMPLEX; DOUBLE STRANDED DNA; PRODIGIOSIN; PYRROLE DERIVATIVE; ZINC COMPLEX; ANTIINFECTIVE AGENT; COPPER; DNA; ZINC;

ARTICLE; ATOMIC PARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DNA CLEAVAGE; GEOMETRY; NONHUMAN; OXIDATION; STREPTOMYCES; BINDING SITE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECT; HYDROLYSIS; METABOLISM; STRUCTURE ACTIVITY RELATION;

ANTI-BACTERIAL AGENTS; BINDING SITES; COPPER; DNA; HYDROLYSIS; MOLECULAR STRUCTURE; PRODIGIOSIN; STRUCTURE-ACTIVITY RELATIONSHIP; ZINC;

EID: 0038341812     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol027165s     Document Type: Article

References (35)

1. For reviews see: (a) Gerber, N. N. Crit. Rev. Microbiol. 1974, 3, 469-485. (b) Bennett, J. W.; Bentley, R. Adv. Appl. Microbiol. 2000, 47, 1-32. (c) Manderville, R. A. Curr. Med. Chem.-Anti-Cancer Agents 2001, 1, 195-218.
2. For reviews see: (a) Gerber, N. N. Crit. Rev. Microbiol. 1974, 3, 469-485. (b) Bennett, J. W.; Bentley, R. Adv. Appl. Microbiol. 2000, 47, 1-32. (c) Manderville, R. A. Curr. Med. Chem.-Anti-Cancer Agents 2001, 1, 195-218.
3. For reviews see: (a) Gerber, N. N. Crit. Rev. Microbiol. 1974, 3, 469-485. (b) Bennett, J. W.; Bentley, R. Adv. Appl. Microbiol. 2000, 47, 1-32. (c) Manderville, R. A. Curr. Med. Chem.-Anti-Cancer Agents 2001, 1, 195-218.
4. Rapoport, H.; Holden, K. G. J. Am. Chem. Soc. 1962, 84, 635-642.
5. (a) Magae, J.; Yamashita, M.; Nagai, K. Ann. N.Y. Acad. Sci. 1993, 685, 339-340.
6. (b) Lee, M. H.; Yamashita, M.; Tsuji, R. F.; Kataoka, T.; Magae, J.; Nagai, K. J. Antibiot. 1998, 51, 92-94.
7. (c) Mortellaro, A.; Songia, S.; Gnocchi, P.; Ferrari, M.; Fornasiero, C. ; D'Alessio, R.; Isetta, A.; Colotta, F.; Golay, J. J. Immunol. 1999, 162, 7102-7109.
8. (d) Stepkowski, S. M.; Erwin-Cohen, R. A.; Behbod, F.; Wang, M. E.; Qu, X.; Tejpal, N.; Nagy, Z. S.; Kahan, B. D.; Kirken, R. A. Blood 2002, 99, 680-689.
9. 50 value for 1 was 2.1 μM. This information is available on the Internet at www.dtp.nci.nih.gov, the NSC number for 1 is 47147-F.
10. (a) Yamamoto, C.; Takemoto, H.; Kuno, K.; Yamamoto, D.; Tsubura, A.; Kamata, K.; Hirata, H.; Yamamoto, K.; Kano, H.; Seki, T.; Inoue, K. Hepatology 1999, 30, 894-902.
11. (b) Yamamoto, D.; Kiyozuka, Y.; Uemura, Y.; Yamamoto, C.; Takemoto, H.; Hirata, H.; Tanaka, K.; Hioki, K.; Tsubura, A. J. Cancer Res. Clin. Oncol. 2000, 126, 191-197.
12. (c) Montaner, B.; Navarro, S.; Piqué, M.; Vilaseca, M.; Martinell, M.; Giralt, E.; Gil, J.; Perez-Tomas, R. Br. J. Pharmacol. 2000, 131, 585-593.
13. (d) Diaz-Ruiz, C.; Montaner, B.; Perez-Tomas, R. Histol. Histopathol. 2001, 2, 415-421.
14. (e) Montaner, B.; Perez-Tomas, R. Life Sci. 2001, 68, 2025-2026.
15. D'Alessio, R.; Bargiotti, A.; Carlini, O.; Colotta, F.; Ferrari, M.; Gnocchi, P.; Isetta, A.; Mongelli, N.; Motta, P.; Rossi, A.; Rossi, M.; Tibolla, M.; Vanotti, E. J. Med. Chem. 2000, 43, 2557-2565.
16. Boger, D. L.; Patel, M. J. Org. Chem. 1988, 53, 1405-1415.
17. Melvin, M. S.; Ferguson, D. C.; Lindquist, N.; Manderville, R. A. J. Org. Chem. 1999, 64, 6861-6869.
18. Melvin, M. S.; Wooton, K. E.; Rich, C. C.; Saluta, G. R.; Kucera, G. L.; Lindquist, N.; Manderville, R. A. J. Inorg. Biochem. 2001, 87, 129-135.
19. Borah, S.; Melvin, M. S.; Lindquist, N.; Manderville, R. A. J. Am. Chem. Soc. 1998, 120, 4557-4562.
20. Melvin, M. S.; Tomlinson, J. T.; Saluta, G. R.; Kucera, G. L.; Lindquist, N.; Manderville, R. A. J. Am. Chem. Soc. 2000, 122, 6333-6334.
21. Keck, M. V.; Manderville, R. A.; Hecht, S. M. J. Am. Chem. Soc. 2001, 123, 8690-8700 and references therein.
22. Fürstner, A.; Grabowski, E. J. Chem. Bio. Chem. 2001, 9, 706-709.
23. Melvin, M. S.; Calcutt, M. W.; Noftle, R. E.; Manderville, R. A. Chem. Res. Toxicol. 2002, 15, 742-748.
24. Melvin, M. S.; Tomlinson, J. T.; Park, G.; Day, C. S.; Saluta, G. R.; Kucera, G. L.; Manderville, R. A. Chem. Res. Toxicol. 2002, 15, 734-741.
25. Zn(II) derivatives are often used as structural models of analogous Cu(I) species, see: (a) Coggin, D. K.; Gonzalez, J. A.; Kook, A. M.; Stanbury, D. M. ; Wilson, L. J. Inorg. Chem. 1991, 30, 1115-1125. (b) Murthy, N. N.; Karlin, K. D. Chem. Commun. 1993, 1236-1238. (c) Yashiro, M.; Ishikubo, A.; Komiyama, M. Chem. Commun. 1997, 83-84.
26. Zn(II) derivatives are often used as structural models of analogous Cu(I) species, see: (a) Coggin, D. K.; Gonzalez, J. A.; Kook, A. M.; Stanbury, D. M. ; Wilson, L. J. Inorg. Chem. 1991, 30, 1115-1125. (b) Murthy, N. N.; Karlin, K. D. Chem. Commun. 1993, 1236-1238. (c) Yashiro, M.; Ishikubo, A.; Komiyama, M. Chem. Commun. 1997, 83-84.
27. Zn(II) derivatives are often used as structural models of analogous Cu(I) species, see: (a) Coggin, D. K.; Gonzalez, J. A.; Kook, A. M.; Stanbury, D. M. ; Wilson, L. J. Inorg. Chem. 1991, 30, 1115-1125. (b) Murthy, N. N.; Karlin, K. D. Chem. Commun. 1993, 1236-1238. (c) Yashiro, M.; Ishikubo, A.; Komiyama, M. Chem. Commun. 1997, 83-84.
28. 3, Z = 8, GOF = 0.916. Final R values (all 2405 data): R1 = 0.1175, wR2 = 0.1214.
29. Solomon, E. I.; Baldwin, M. J.; Lowery, M. D. Chem. Rev. 1992, 92, 521-542.
30. Wasserman, H. H.; McKeon, J. E.; Smith, L. A.; Forgione, P. Tetrahedron 1966, Suppl. 8, Part II, 647-662, contains elemental analyses of Zn and Co complexes of 1.
31. 3, Z = 2, GOF = 0.873. Final R values (all 4215 data): R1 = 0.2214, wR2 = 0.1600. See Supporting Information for full details.
32. Rizzo, V.; Morelli, A.; Pinciroli, V., Sciangula, D.; D'Allessio, R. J. Pharm. Sci. 1999, 88, 73-78.
33. + 628 and 702.
34. Klinman, J. P. Chem. Rev. 1996, 96, 2541-2561.
35. Dolphin, D.; Felton, R. H. Acc. Chem. Res. 1974, 7, 26-32.